Relationship of uric acid with progression of kidney disease. - Wikidata - wikimedia - TriplyDB

Relationship of uric acid with progression of kidney disease.

Relationship of uric acid with progression of kidney disease.

http://www.wikidata.org/entity/Q51909525

about

Associations Between Hyperuricemia and Chronic Kidney Disease: A Review Uric Acid as a Marker of Kidney Disease: Review of the Current Literature Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review Serum urate levels and the risk of hip fractures: data from the Cardiovascular Health Study.Metabolic syndrome, serum uric acid and renal risk in patients with T2D.Any link of gout disease control among hypertensive patients and onset of end-stage renal disease? Results from a population-based study Association of a polymorphism in a gene encoding a urate transporter with CKD progression.Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data.Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies.Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease Uric acid: a novel mediator and marker of risk in chronic kidney disease?Chronic kidney disease in gout in a managed care setting Comorbidities in patients with crystal diseases and hyperuricemia.Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002 The relationship between serum uric acid and chronic kidney disease among Appalachian adults Chronic kidney disease prediction is an inexact science: The concept of "progressors" and "nonprogressors"Association of renal manifestations with serum uric acid in Korean adults with normal uric acid levels SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria Hypertension and the development of new onset chronic kidney disease over a 10 year period: a retrospective cohort study in a primary care setting in Malaysia.The association between hyperuricemia and betel nut chewing in Taiwanese men: a cross-sectional study.Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization Serum uric acid and chronic kidney disease: the role of hypertension.The risk of Parkinson disease associated with urate in a community-based cohort of older adults.Allopurinol is an independent determinant of improved arterial stiffness in chronic kidney disease: a cross-sectional study.Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study.Effect of uric-acid-lowering therapy on progression of chronic kidney disease: a meta-analysis.Uric acid as a mediator of diabetic nephropathy.Association between Serum Uric Acid Levels and Diabetes Mellitus.Urinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF/HDMS.Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.Serum Uric Acid and Renal Transplantation Outcomes: At Least 3-Year Post-transplant Retrospective Multivariate Analysis Sugar-sweetened soda consumption, hyperuricemia, and kidney disease.Hyperuricemia: An Early Marker for Severity of Illness in Sepsis.The association between blood pressure level and serum uric acid concentration in hemodialysis patients Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan.Risk of end-stage renal disease associated with gout: a nationwide population study.Comparative pharmacokinetic study of the main components of cortex fraxini after oral administration in normal and hyperuricemic rats.

P2860

Q26796333-68A41A4D-AE89-45F6-82FA-2C4EE5EB68EF Q26849588-95AF5195-B8CA-4AD4-9F4E-D8DC10F7CD23 Q28079134-7DAB9A16-5304-43F0-8052-3A7553556CB2 Q30876545-77F6829C-2CD4-4B5C-8DE8-DE9BFFB6BA81 Q33579624-C78EF08A-74C6-4EA8-8387-31EAA148DA7F Q33655400-4495E317-DB73-4FA1-8CC2-F4CEC4EFED2F Q33715840-7B6597B4-C800-43C8-B5E2-4CEC68147D11 Q33784030-63F5FEA6-BFAA-44AD-B80C-CEF49A9C6822 Q33800813-51759519-34DC-4D82-98AC-6E8F9F392634 Q33868118-DFDA862C-9AD5-444D-A264-D9412F151B48 Q33913892-9B655F3C-4DAC-4B99-96AB-671E774507EF Q33980619-2BEC9151-B71A-4374-A8D7-10E486854F29 Q34157725-E9ED0E67-3C62-40C5-8CB7-CD8D48DE2F6A Q34254522-FDBAFB11-E30C-4F31-8A25-A7A2BAB20B48 Q34308220-50DDB508-8E69-4FCE-984F-F9EDDBF0CA38 Q34367656-DFB63331-FF8B-4E1A-B534-B7AF72AAA5B4 Q34369036-CC04E183-17CA-4A73-B6E2-E71904AC7DE0 Q34470786-4817EFA0-25DB-48E2-A9F2-1ADA92043164 Q34520037-F618E767-8504-4CBE-913C-8B6D56113DCD Q34524645-0E1F18C5-ED72-4A7F-A2C7-C5EBF3DB7432 Q34737229-74A26C1E-6F81-495D-B30C-9C4970E70B71 Q34976710-76EC350B-4FE3-4485-AE9E-FD51CA7018F2 Q35046376-06739776-8097-4F1F-98F2-BDF1FA0F5AC2 Q35050256-AC821800-C0F8-4F92-82FE-503A8A25E2B0 Q35071745-803C4868-8373-47A7-B441-FE07AFFF78E9 Q35121532-759A19D0-9B9F-41B5-9EBC-A58FA2E3B02E Q35134716-AA13CC77-2C17-44F6-966F-3E99C5C8AA01 Q35227649-D0F6869B-C92E-426C-85CB-A2BB0B9657AF Q35393446-231622D0-52D4-4401-891B-9AC47013E81D Q35550911-946D64B4-0AFC-4806-9D11-7AE98B035894 Q35600812-2080D7AC-E75E-4E8C-A333-0DB29EB0B283 Q35605560-7FD69281-A779-4DB5-AF7A-27BE95B950D5 Q35620128-0A581E8B-1776-4923-B7A6-F72CD6588B60 Q35711594-44B9DE84-AABF-4062-95B6-03271C0FE19E Q35820430-D10BF171-F9CF-47CE-940A-AEBA3399F80E Q35941771-26D8379F-C5D4-429B-85B8-7E1DA6853655 Q35981124-ECAA4C78-2DA4-4910-A8D4-916356A3CD9A Q36166872-C1084D9A-5650-478E-A699-DA7E8DACA96C Q36245837-1BC4F607-8CB4-41E0-A0FC-9B02B3BF3664 Q36248432-A620216C-D633-47B4-95C4-1E09B35F3BF4

P2860

Relationship of uric acid with progression of kidney disease.

http://www.wikidata.org/entity/Q51909525

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Relationship of uric acid with progression of kidney disease.

@en

Relationship of uric acid with progression of kidney disease.

@nl

type

label

Relationship of uric acid with progression of kidney disease.

@en

Relationship of uric acid with progression of kidney disease.

@nl

prefLabel

Relationship of uric acid with progression of kidney disease.

@en

Relationship of uric acid with progression of kidney disease.

@nl

P1433

Q51909525-A8A16D68-4433-4857-A4FF-BCFC16261D64

P1476

Q51909525-F7D71C17-2832-4E24-94D4-FBCACFAD3BF9

P2093

Q51909525-51D4569B-34F4-427F-B6D4-20186DA21D70

Q51909525-5D3FFE4E-B749-4533-B457-735541B77779

Q51909525-802AB7DE-6F64-484D-8DB3-F69D08F17446

Q51909525-E392EE95-3A61-42E0-ADAD-95FFD0F91C0B

Q51909525-FEFA7272-255A-43E1-8C3D-EFFC4983A4C7

P304

Q51909525-4C890F08-F117-4B55-A314-5CE3BFA69591

P31

Q51909525-593FD54D-E51B-466C-B07D-A0E6E82BDF81

P356

Q51909525-5F5CCB42-43D3-4473-B730-09CB4CB3653E

P433

Q51909525-A62F5543-8FBC-455C-9599-196D5ED8EB6B

P478

Q51909525-7E1C1F84-831F-407C-A6F6-C9284443D8FE

P50

Q51909525-1403BA43-78BA-43F4-A89F-680D97EBE6D3

Q51909525-79C39998-0C5F-4B0A-A0BE-933F59712ED1

Q51909525-7B7987DA-ADB1-409F-AB0B-C31DC9FC8C69

Q51909525-A4532F0D-96B3-403A-9952-E638176D0648

P577

Q51909525-ABD4ACA9-2242-4A0B-A418-17B666BF1A12

P698

Q51909525-C5B5826C-A8E5-4580-810F-72C31725410D

P356

J.AJKD.2007.05.013

P1433

American Journal of Kidney Diseases

P1476

Relationship of uric acid with progression of kidney disease.

@en

P2093

Jan Kirk Carney

http://www.w3.org/2001/XMLSchema#string

Linda F Fried

http://www.w3.org/2001/XMLSchema#string

Mark J Sarnak

http://www.w3.org/2001/XMLSchema#string

Michel Chonchol

http://www.w3.org/2001/XMLSchema#string

Ronit Katz

http://www.w3.org/2001/XMLSchema#string

P304

239-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.AJKD.2007.05.013

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

David S Siscovick

Bryan R Kestenbaum

Michael G Shlipak

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17660025

http://www.w3.org/2001/XMLSchema#string